Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Liang-Shang Gan

Showing results (1-10 of 39) with videos related to

Pageof 4
Sort By:
International Journal of Cell Biology|July 11, 2013
Receptor-mediated endocytosis and brain delivery of therapeutic biologicsGuangqing Xiao, Liang-Shang Gan
Journal of Pharmaceutical Sciences|June 27, 2013
Plasma protein binding: from discovery to developmentTonika Bohnert, Liang-Shang Gan
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 17, 2005
Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomibVinita Uttamsingh, Chuang Lu, Gerald Miwa, et al.
Current Drug Metabolism|May 17, 2007
Evaluation of drug-transporter interactions using in vitro and in vivo modelsCindy Q Xia, Mark N Milton, Liang-Shang Gan
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Breast cancer resistance protein in pharmacokinetics and drug-drug interactionsCindy Q Xia, Johnny J Yang, Liang-Shang Gan
Pharmaceutical Research|June 20, 2018
Fampridine is a Substrate and Inhibitor of Human OCT2, but not of Human MATE1, or MATE2KGuangqing Xiao, Christopher Rowbottom, Carri Boiselle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 12, 2011
A refined cytochrome P540 IC₅₀ shift assay for reliably identifying CYP3A time-dependent inhibitorsPing Li, Chuang Lu, Suresh K Balani, et al.
Current Drug Metabolism|December 8, 2004
CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and developmentGang Luo, Thomas Guenthner, Liang-Shang Gan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2002
Metabolism of (S)-5,6-difluoro-4-cyclopropylethynyl-4-trifluoromethyl-3, 4-dihydro-2(1H)-quinazolinone, a non-nucleoside reverse transcriptase inhibitor, in human liver microsomes. Metabolic activation and enzyme kineticsHao Chen, Weiqi Chen, Liang-Shang Gan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 25, 2007
Esterase inhibition by grapefruit juice flavonoids leading to a new drug interactionPing Li, Patrick S Callery, Liang-Shang Gan, et al.
Pageof 4

Showing results (1-10 of 39) with videos related to

Sort By:
Pageof 4
International Journal of Cell Biology|July 11, 2013
Receptor-mediated endocytosis and brain delivery of therapeutic biologicsGuangqing Xiao, Liang-Shang Gan
Journal of Pharmaceutical Sciences|June 27, 2013
Plasma protein binding: from discovery to developmentTonika Bohnert, Liang-Shang Gan
Drug Metabolism and Disposition: the Biological Fate of Chemicals|August 17, 2005
Relative contributions of the five major human cytochromes P450, 1A2, 2C9, 2C19, 2D6, and 3A4, to the hepatic metabolism of the proteasome inhibitor bortezomibVinita Uttamsingh, Chuang Lu, Gerald Miwa, et al.
Current Drug Metabolism|May 17, 2007
Evaluation of drug-transporter interactions using in vitro and in vivo modelsCindy Q Xia, Mark N Milton, Liang-Shang Gan
Expert Opinion on Drug Metabolism & Toxicology|July 26, 2006
Breast cancer resistance protein in pharmacokinetics and drug-drug interactionsCindy Q Xia, Johnny J Yang, Liang-Shang Gan
Pharmaceutical Research|June 20, 2018
Fampridine is a Substrate and Inhibitor of Human OCT2, but not of Human MATE1, or MATE2KGuangqing Xiao, Christopher Rowbottom, Carri Boiselle, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|March 12, 2011
A refined cytochrome P540 IC₅₀ shift assay for reliably identifying CYP3A time-dependent inhibitorsPing Li, Chuang Lu, Suresh K Balani, et al.
Current Drug Metabolism|December 8, 2004
CYP3A4 induction by xenobiotics: biochemistry, experimental methods and impact on drug discovery and developmentGang Luo, Thomas Guenthner, Liang-Shang Gan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|December 18, 2002
Metabolism of (S)-5,6-difluoro-4-cyclopropylethynyl-4-trifluoromethyl-3, 4-dihydro-2(1H)-quinazolinone, a non-nucleoside reverse transcriptase inhibitor, in human liver microsomes. Metabolic activation and enzyme kineticsHao Chen, Weiqi Chen, Liang-Shang Gan, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|April 25, 2007
Esterase inhibition by grapefruit juice flavonoids leading to a new drug interactionPing Li, Patrick S Callery, Liang-Shang Gan, et al.
Pageof 4